These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12126893)

  • 61. [Vaccination is not always sufficient to prevent vertical transmission of hepatitis B virus].
    Buster EH; de Man RA
    Ned Tijdschr Geneeskd; 2014; 158():A8151. PubMed ID: 25322358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Combined passive and active immunization of infants of HbsAg-positive mothers].
    Mazel JA; Heijtink RA; Schalm SW; Gerards LJ; Botman MJ; Bänffer JR; de Gast GC; Nuyten AS; Wladimiroff JW; Zwijnenberg J
    Ned Tijdschr Geneeskd; 1985 Mar; 129(13):590-4. PubMed ID: 3990848
    [No Abstract]   [Full Text] [Related]  

  • 63. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunization strategies for the elimination of hepatitis B.
    Reece SM
    Nurse Pract; 1993 Feb; 18(2):42-5, 49-50. PubMed ID: 8455811
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations.
    Wong WC; Tsang KK
    Vaccine; 1994; 12(3):229-34. PubMed ID: 8165855
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Limited benefit of hepatitis B immunoglobulin prophylaxis in children of hepatitis B e antigen-negative mothers.
    Lee LY; Aw MM; Saw S; Rauff M; Tong PY; Lee GH
    Singapore Med J; 2016 Oct; 57(10):566-569. PubMed ID: 26778725
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Revaccination of non-responding infants delivered by HBsAg-positive mothers.
    Hasanjani Roushan MR; Pasha YZ; Saghebi R; Kohi F
    Eur J Clin Microbiol Infect Dis; 2005 Jun; 24(6):434-5. PubMed ID: 15937660
    [No Abstract]   [Full Text] [Related]  

  • 68. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors.
    Ngui SL; Andrews NJ; Underhill GS; Heptonstall J; Teo CG
    Clin Infect Dis; 1998 Jul; 27(1):100-6. PubMed ID: 9675462
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cost-effectiveness analysis of preventing mother-to-child transmission of hepatitis B by injecting hepatitis B immune globulin.
    Guo Y; Zhang W; Zhang Y; Lin X; Zhang B; Chen C; Du Y
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1363-9. PubMed ID: 22922527
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of the compliance with recommended procedures in newborns exposed to HBsAg-positive mothers: a multicenter collaborative study.
    Heininger U; Vaudaux B; Nidecker M; Pfister RE; Posfay-Barbe KM; Bachofner M; Hoigné I; Gnehm HE
    Pediatr Infect Dis J; 2010 Mar; 29(3):248-50. PubMed ID: 19935120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 20 μg hepatitis B vaccination reduced the risk of low responsiveness in infants with HLA-II risk genotype of HBsAg positive mothers.
    Cao M; Wu Y; Wen S; Pan Y; Wang C; Zhang X; Kong F; Lu Y; Wang C; Niu J; Li J; Jiang J
    Infect Genet Evol; 2018 Sep; 63():243-248. PubMed ID: 29883771
    [TBL] [Abstract][Full Text] [Related]  

  • 72. What is the best hepatitis B vaccination strategy for South Africa?
    Karim SS
    S Afr Med J; 1998 Jun; 88(6):693-4. PubMed ID: 9687844
    [No Abstract]   [Full Text] [Related]  

  • 73. Prevention of perinatal hepatitis B through enhanced case management--Connecticut, 1994-95, and the United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(27):584-7. PubMed ID: 9132578
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Infection control--screen saver.
    Pendleton E
    Nurs Times; 1997 Sep 10-16; 93(37):65-8. PubMed ID: 9348950
    [No Abstract]   [Full Text] [Related]  

  • 75. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.
    Euler GL; Copeland JR; Rangel MC; Williams WW
    Pediatr Infect Dis J; 2003 Feb; 22(2):123-9. PubMed ID: 12586975
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ; Saab S; Meyerhoff AS
    J Am Coll Health; 2003 May; 51(6):227-36. PubMed ID: 14510025
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 Jun; 32(6):715-8. PubMed ID: 8613350
    [No Abstract]   [Full Text] [Related]  

  • 78. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers.
    Poovorawan Y; Sanpavat S; Chumdermpadetsuk S; Safary A
    Arch Dis Child Fetal Neonatal Ed; 1997 Jul; 77(1):F47-51. PubMed ID: 9279183
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prevention of mother-to-child transmission of hepatitis B virus].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):881-884. PubMed ID: 28073406
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The importance of being earnest: following up a low level hepatitis B surface antigen (HBsAg) result.
    De Gascun CF; Fraher M; Crean M; Connell J; Hall WW
    J Clin Virol; 2010 Oct; 49(2):79-81. PubMed ID: 20570554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.